United States · FDA National Drug Code directory
Diltiazem Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-672_ecddf1f1-b8e7-4a08-8f00-6cc484092a5f
- Product NDC
- 47335-672
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Diltiazem Hydrochloride
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101115
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-672-13) · 47335-672-13
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-672-18) · 47335-672-18
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-672-19) · 47335-672-19
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-672-81) · 47335-672-81
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-672-83) · 47335-672-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →